e-therapeutics has completed its planned £28.9 million fundraise weeks after delisting from the London Stock Exchange – and will now consider an IPO in New York. The MedTech, which slammed the risk appetite of UK investors in April, cancelled its shares on the junior AIM market in early May after 17 years as a publicly … Continue reading e-therapeutics eyes NASDAQ after raising £29m